Back
Procter & Gamble Co. Vs. United Therapeutics Corp. Industry Stock Comparison
Sell
43
PG
Procter & Gamble Co.
Last Price:
$143.99
Seasonality Move:
-1.1%
Buy
55
UTHR
United Therapeutics Corp.
Last Price:
$496.94
Seasonality Move:
3.94%
Sell
43
Procter & Gamble Co. (PG)
is a Sell
Is Procter & Gamble Co. a Buy, Sell or Hold?
-
The current Procter & Gamble Co. [PG] share price is $144.57. The Score for PG is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
PG is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
United Therapeutics Corp. (UTHR)
is a Buy
Is United Therapeutics Corp. a Buy, Sell or Hold?
-
The current United Therapeutics Corp. [UTHR] share price is $502.90. The Score for UTHR is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
UTHR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PG Stock Price Chart
What is Procter & Gamble Co.'s stock price today?
-
The Procter & Gamble Co. share price today is $144.57Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PG is experiencing slight buying pressure.
UTHR Stock Price Chart
What is United Therapeutics Corp.'s stock price today?
-
The United Therapeutics Corp. share price today is $502.90Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UTHR is experiencing selling pressure, which indicates risk of future bearish movement.
PG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 40.05 | Buy |
| Relative Strength Index (14 RSI): | 48.54 | Sell |
| Chaikin Money Flow: | 851347 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (141.84 - 147.82) | Sell |
| Bollinger Bands (100): | (145.65 - 156.13) | Sell |
UTHR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 141.19 | Buy |
| Relative Strength Index (14 RSI): | 58.24 | Buy |
| Chaikin Money Flow: | -137095 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (479.39 - 506.87) | Buy |
| Bollinger Bands (100): | (363.96 - 489.06) | Buy |
PG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 144.68 | Sell |
| 20-day SMA: | 143.9 | Buy |
| 50-day SMA: | 146.89 | Sell |
| 200-day SMA: | 156.38 | Sell |
| 8-day EMA: | 125.09 | Buy |
| 20-day EMA: | 79.64 | Buy |
| 50-day EMA: | 39.61 | Buy |
| 200-day EMA: | 11.12 | Buy |
UTHR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 510.5 | Sell |
| 20-day SMA: | 495.8 | Buy |
| 50-day SMA: | 470.07 | Buy |
| 200-day SMA: | 363.17 | Buy |
| 8-day EMA: | 440.95 | Buy |
| 20-day EMA: | 281.01 | Buy |
| 50-day EMA: | 139.77 | Buy |
| 200-day EMA: | 39.25 | Buy |
Procter & Gamble Co. Earnings Growth & PG Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and an increase next year of $0.23 per share.
United Therapeutics Corp. Earnings Growth & UTHR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.90 per share, and an increase next year of $1.85 per share.
Procter & Gamble Co. Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
United Therapeutics Corp. Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||